HappeningToo topic

Daratumumab reports

Browse community reports connected to Daratumumab. These reports can show that other people are describing similar experiences, but they do not prove that Daratumumab caused a symptom or reaction.

⚕️ Medicine safety note

Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.

26 problems

Abdominal Pain while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and abdominal pain appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and back pain appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Chest Discomfort while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and chest discomfort appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Chills while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and chills appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and constipation appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and cough appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and decreased appetite appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and dehydration appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and diarrhea appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and dizziness appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and fatigue appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and headache appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and hypotension appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and insomnia appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and itching appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and malaise appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and muscle spasms appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and nausea appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and pain appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and peripheral swelling appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and rash appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and shortness of breath appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tremor while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and tremor appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and vomiting appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and weakness appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Daratumumab

FDA FAERS contains adverse-event reports in which Daratumumab and weight decreased appear together. This does not establish that Daratumumab caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →